By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BIND Therapeutics 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-491-3400 Fax: 617-491-0351


Company News
Data From Three Abstracts Validating Potential Of BIND Therapeutics (BIND)’ Accurins To Be Presented At American Association for Cancer Research Annual Meeting 3/19/2015 12:48:18 PM
BIND Therapeutics (BIND) Reports Fourth Quarter And Full Year 2014 Financial Results 3/11/2015 10:17:25 AM
BIND Therapeutics (BIND) Appoints Andrew Hirsch As Acting President And Chief Executive Officer 3/11/2015 8:43:28 AM
BIND Therapeutics (BIND) To Report Fourth Quarter And Year-End 2014 Financial Results On March 11, 2015 3/2/2015 10:39:08 AM
BIND Therapeutics (BIND) To Present At Cowen and Company 35th Annual Healthcare Conference 2/19/2015 12:26:18 PM
BIND Therapeutics (BIND) Announces Closing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 2/10/2015 1:39:54 PM
BIND Therapeutics (BIND) Prices Public Offering Of Common Stock And Warrants To Purchase Common Stock 2/5/2015 10:49:44 AM
BIND Therapeutics (BIND) Amends Credit Facility From Hercules Technology III, L.P. To Accelerate Accurin Pipeline Growth 1/26/2015 10:28:59 AM
BIND Therapeutics (BIND) Co-Founder Publishes Nanotechnology Article In JAMA 1/22/2015 8:47:17 AM
BIND Therapeutics (BIND) Provides Clinical Update For BIND-014 And 2015 Strategic Overview 1/8/2015 2:15:26 PM